Vanderbilt University Medical Center and AstraZeneca join forces to identify potential COVID-19 treatments
Apr. 9, 2020—Vanderbilt University Medical Center and the global biopharmaceutical company AstraZeneca have joined forces to identify candidates for antibody-based treatments that could protect people exposed to the 2019 novel coronavirus disease, COVID-19.
Oct. 4, 2018—An international team led by researchers at Vanderbilt University Medical Center sheds new light on the cause of pulmonary fibrosis and demonstrates a way to impede the disease.
Sep. 9, 2015—The extraordinary achievements of nine Vanderbilt endowed chair holders were lauded at a Sept. 8 celebration during which generous donors were thanked.
Jan. 10, 2014—Read about faculty and staff awards and achievements in the latest edition of "Kudos."
Oct. 31, 2013—Two of Nashville biggest industries — music and health care — come together in the Nashville Opera’s upcoming production of “The Man Who Mistook His Wife for a Hat,” based on a medical case study from the book of the same name by the popular author and neurologist Oliver Sacks.
Dec. 5, 2012—WHAT HAPPENS WHEN YOU START SEEING PATIENTS WHO ARE GETTING SICKER BY THE MINUTE? AND NORMAL TREATMENTS AREN’T WORKING? VANDERBILT DOCTORS AND TECHNICIANS QUICKLY WORKED TO SOLVE THE MYSTERY SURROUNDING THE DEADLIEST OUTBREAK OF FUNGAL MENINGITIS THAT HAS EVER HIT OUR NATION. CAROLE BARTOO TAKES US BEHIND THE SCENES TO THE LAB THAT BECAME GROUND...
Apr. 10, 2012—Researchers at Vanderbilt University have discovered that an unusual set of immune cells, called invariant natural killer T cells, can exacerbate obesity-related inflammation.